- English (USA)
- English (UK)
- English (India)
- English (Australia)
- English (South Africa)
- English (Philippines)
- English (Nigeria)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Pulse Biosciences Inc (PLSE)
Pulse Biosciences Inc stock price live, this page displays NASDAQ PLSE stock exchange data. View the PLSE premarket stock price ahead of the market session or assess the after hours quote. Monitor the latest movements within the Pulse Biosciences Inc real time stock price chart below.
What Is the Pulse Biosciences Inc Stock Price Today?
The Pulse Biosciences Inc stock price today is 49.25.
What Is the Stock Symbol for Pulse Biosciences Inc?
The stock symbol for Pulse Biosciences Inc is "PLSE."
What Stock Exchange Does Pulse Biosciences Inc Trade On?
Pulse Biosciences Inc is listed and trades on the NASDAQ stock exchange.
Is Pulse Biosciences Inc a Good Stock to Buy?
Determining whether Pulse Biosciences Inc—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the PLSE quote. (ISIN: US74587B1017)
What Is the Pulse Biosciences Inc Stock Price Today?
The Pulse Biosciences Inc stock price today is 49.25.
What Is the Stock Symbol for Pulse Biosciences Inc?
The stock symbol for Pulse Biosciences Inc is "PLSE."
What Stock Exchange Does Pulse Biosciences Inc Trade On?
Pulse Biosciences Inc is listed and trades on the NASDAQ stock exchange.
Is Pulse Biosciences Inc a Good Stock to Buy?
Determining whether Pulse Biosciences Inc—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the PLSE quote. (ISIN: US74587B1017)
49.25
-0.50(-1.00%)
Real-time Data·
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
48.75
49.93
52 wk Range
12.56
58.90
PLSE is not included in our AI-picked strategies. See which stocks are.
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
48.7549.93
52 wk Range
12.5658.90
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
PLSE Scorecard
Company’s Health
Assesses a company's financial position by analyzing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Neutral
Analysts Sentiment
Strong Buy
Price Target
56.50
Upside
+14.72%
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Suffers from weak gross profit margins
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Neutral
Technical Indicators
Buy
Moving Averages
Sell
Analyst Ratings
6 Buy
0 Hold
0 Sell
Ratings:
6 analysts
Overall Consensus
Strong Buy
Analysts 12-Month Price Target:
Average 56.50
(+14.72% Upside)
Pulse Biosciences Inc Earnings Call Summary for Q2/2026
- Pulse Biosciences posted Q2 2026 adjusted loss of $0.36/share vs. $0.28 estimate; revenue of $400K missed $600K forecast by 33%, though shares rose 0.42% after hours.
- NANOPULSE-AF pivotal trial enrollment ahead of schedule, now expected to complete early October 2026, three months early; target raised to 164 patients from 145.
- Cash position strengthened to $101.6M at quarter-end from $68.3M prior quarter, bolstered by $46.8M ATM proceeds; company has at least five quarters of runway.
- Non-GAAP operating expenses rose 38.5% YoY to $20.5M; management expects costs to remain in current range before rising ahead of regulatory milestones.
- Key milestones include cardiac catheter CE mark submission H2 2026, surgical clamp CE filing by year-end 2026, and NANOCLAMP-AF study completion by H1 2027.
Last Updated: 2026-08-06, 06:04 p/m
Read Full TranscriptEarnings
Latest Release
Aug 06, 2026
EPS / Forecast
-0.36 / -0.28
Revenue / Forecast
400K / 600K
Compare PLSE to Peers and Sector
Metrics to compare | PLSE | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipPLSEPeersSector | |
|---|---|---|---|---|
P/E Ratio | −43.9x | −1.7x | −0.3x | |
PEG Ratio | 4.61 | −0.12 | 0.00 | |
Price/Book | 35.3x | 2.3x | 2.6x | |
Price / LTM Sales | 2,963.0x | 2.1x | 3.0x | |
Upside (Analyst Target) | 13.6% | 82.9% | 58.2% | |
Fair Value Upside | Unlock | 16.1% | 7.5% | Unlock |
Pulse Biosciences, Inc. operates as a novel bioelectric medicine company. It offers nPulse System, a novel Nanosecond Pulsed-Field Ablation delivery platform to treat benign lesions of the skin; nPulse Vybrance Percutaneous Electrode system for soft tissue ablation in surgical setting; nPulse Cardiac Surgical Clamp designed for use in surgical treatment of atrial fibrillation (AF); nPulse Cardiac Catheter System designed to provide a circumferential, or circular, ablation in a single treatment cycle; and nPulse Console, a software-enabled console-based platform designed to accommodate the clinical workflow preferred by physicians. The company was formerly known as Electroblate, Inc. and changed its name to Pulse Biosciences, Inc. in December 2015. Pulse Biosciences, Inc. was incorporated in 2014 and is headquartered in Miami, Florida.
Ownership
Ownership Overview
Top Holders
People Also Watch
FAQ
What Is the Pulse Biosciences (PLSE) Stock Price Today?
The Pulse Biosciences stock price today is 49.25 USD.
What Stock Exchange Does Pulse Biosciences Trade On?
Pulse Biosciences is listed and trades on the Nasdaq Stock Exchange.
What Is the Stock Symbol for Pulse Biosciences?
The stock symbol for Pulse Biosciences is "PLSE."
What Is the Pulse Biosciences Market Cap?
As of today, Pulse Biosciences market cap is 3.48B USD.
What Is Pulse Biosciences's Earnings Per Share (TTM)?
The Pulse Biosciences EPS (TTM) is -1.18.
When Is the Next Pulse Biosciences Earnings Date?
Pulse Biosciences will release its next earnings report on Nov 16, 2026.
From a Technical Analysis Perspective, Is PLSE a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Neutral.
How Many Times Has Pulse Biosciences Stock Split?
Pulse Biosciences has split 0 times.
How Many Employees Does Pulse Biosciences Have?
Pulse Biosciences has 116 employees.
What is the current trading status of Pulse Biosciences (PLSE)?
As of Oct 07, 2026, Pulse Biosciences (PLSE) is trading at a price of 49.25 USD, with a previous close of 49.75 USD. The stock has fluctuated within a day range of 48.75 USD to 49.93 USD, while its 52-week range spans from 12.56 USD to 58.90 USD.
What Is Pulse Biosciences (PLSE) Price Target According to Analysts?
The average 12-month price target for Pulse Biosciences is 56.50 USD, with a high estimate of 73 USD and a low estimate of 35 USD. 6 analysts recommend buying the stock, while 0 suggest selling, leading to an overall rating of Strong Buy. The stock has an +14.72% Upside potential.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.